8-K Announcements
6Material company update
Apr 16, 2026·SEC
Material company update
Mar 31, 2026·SEC
Material company update
Mar 13, 2026·SEC
Modular Medical, Inc.(MODD)Earnings, Financials & Key Ratios
MODD•NASDAQ
$3.91
$8M mkt cap·Price updated May 6, 2026
AboutModular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.Show more
- Revenue$0
- EBITDA-$18M-5.1%
- Net Income-$19M-7.8%
- EPS (Diluted)-15.30+34.6%
- ROE-131.58%+37.4%
- ROIC-344.61%+17.2%
- Debt/Equity0.05-53.7%
MODD Key Insights
Modular Medical, Inc. (MODD) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Trading at only 0.3x book value
✗Weaknesses
- ✗Profits declining 28.7% over 5 years
- ✗Weak momentum: RS Rating 3 (bottom 3%)
- ✗Shares diluted 65.4% in last year
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
MODD Price & Volume
Modular Medical, Inc. (MODD) stock price & volume — 10-year historical chart
Loading chart...
MODD Growth Metrics
Modular Medical, Inc. (MODD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-47.32%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM7.55%
Return on Capital
10 Years-194.79%
5 Years-312.74%
3 Years-166.45%
Last Year-127.74%
MODD Recent Earnings
Modular Medical, Inc. (MODD) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (17%)
Q1 2026Latest
Feb 17, 2026EPS
$3.30
Est $3.00
-10.0%
Revenue
—
Est $800,000
Q4 2025
Nov 14, 2025EPS
$0.14
Est $0.10
-40.0%
Revenue
—
Est $400,000
Q3 2025
Aug 14, 2025EPS
$0.12
Est $0.10
-20.0%
Revenue
—
Est $200,000
Q3 2025
Jun 20, 2025EPS
$0.12
Est $0.11
-9.1%
Revenue
—
Est $400,000
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 17, 2026 | $3.30vs $3.00-10.0% | —vs $800,000 |
| Q4 2025 | Nov 14, 2025 | $0.14vs $0.10-40.0% | —vs $400,000 |
| Q3 2025 | Aug 14, 2025 | $0.12vs $0.10-20.0% | —vs $200,000 |
| Q3 2025 | Jun 20, 2025 | $0.12vs $0.11-9.1% | —vs $400,000 |
Based on last 12 quarters of dataView full earnings history →
MODD Peer Comparison
Modular Medical, Inc. (MODD) competitors in Diabetes care and insulin delivery — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 PODD | 10.61B | 151.17 | 43.44 | 30.73% | 10.44% | 21.38% | 0.69 | |
 TNDM | 1.24B | 18.03 | -5.93 | 7.93% | -20.17% | -141.98% | 2.86 | |
 NVCR | 1.88B | 16.50 | -13.52 | 8.28% | -25.66% | -50.82% | 0.85 | |
 MASI | 9.35B | 178.49 | -63.74 | -27.1% | 4.9% | 9.08% | 0.78 | |
 DXCM | 23.29B | 60.36 | 28.88 | 15.6% | 19.31% | 33.83% | 0.51 | |
 ABT | 149.97B | 86.25 | 11.29 | 4.59% | 31.88% | 27.26% | 0.32 | |
 MDT | 99.48B | 77.60 | 21.50 | 3.62% | 13% | 9.45% | 0.59 | |
 RCEL | 135.13M | 4.42 | -2.54 | 11.45% | -67.85% |
Compare MODD vs Peers
Modular Medical, Inc. (MODD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
MODD Income Statement
Modular Medical, Inc. (MODD) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Jun'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 1.86K | 14.47K | 35.43K | 181.84K | 196.92K | 355.45K | 768K | 1.43M | 1.56M |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0▲ 0% | -1.86K▲ 0% | -14.47K▼ 677.4% | -35.43K▼ 144.9% | -181.84K▼ 413.2% | -196.92K▼ 8.3% | -355.45K▼ 80.5% | -768K▼ 116.1% | -1.43M▼ 86.6% | -1.56M▲ 0% |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | -677.43% | -144.89% | -413.23% | -8.29% | -80.5% | -116.07% | -86.59% | - |
| Operating Expenses | 91.05K | 666.16K | 2.58M | 5.31M | 7.15M | 14.73M | 13.52M | 16.76M | 17.61M | 25.3M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 91.05K | 331.66K | 694.95K | 2.28M | 3.07M | 7M | 4.46M | 3.88M | 2.92M | 6.79M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 0 | 332.64K | 1.88M | 3.03M | 4.08M | 7.73M | 9.06M | 12.88M | 14.7M | 18.94M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -430K |
| Operating Income | -91.05K▲ 0% | -666.16K▼ 631.6% | -2.58M▼ 286.9% | -5.35M▼ 107.5% | -7.34M▼ 37.2% | -14.93M▼ 103.4% | -13.88M▲ 7.0% | -17.53M▼ 26.3% | -19.05M▼ 8.7% | -26.86M▲ 0% |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -591.72% | -631.64% | -286.89% | -107.5% | -37.19% | -103.45% | 7.02% | -26.3% | -8.67% | - |
| EBITDA | -61.63K | -664.3K | -2.56M | -5.31M | -7.15M | -14.73M | -13.52M | -16.76M | -17.61M | -25.3M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | - | -977.84% | -285.79% | -107.29% | -34.68% | -105.87% | 8.19% | -23.95% | -5.1% | -45.96% |
| D&A (Non-Cash Add-back) | 29.42K | 1.86K | 14.47K | 35.43K | 181.84K | 196.92K | 355.45K | 768K | 1.43M | 1.56M |
| EBIT | -29.42K | -666.16K | -2.58M | -5.32M | -7.34M | -15.88M | -13.88M | -17.47M | -18.82M | -26.66M |
| Net Interest Income | 0 | 0 | 0 | 28.75K | -39.66K | -2.75M | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 8.52K | 39.39K | 28.75K | 130 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 15.51K | 0 | 0 | 0 | 39.79K | 2.75M | 0 | 0 | 0 | 0 |
| Other Income/Expense | 62.59K | 8.52K | 39.39K | 28.75K | -39.66K | -3.7M | 975 | 61K | 226K | 78K |
| Pretax Income | -106.56K▲ 0% | -657.65K▼ 517.2% | -2.54M▼ 285.9% | -5.32M▼ 109.6% | -7.38M▼ 38.7% | -18.63M▼ 152.6% | -13.88M▲ 25.5% | -17.47M▼ 25.9% | -18.82M▼ 7.8% | -26.78M▲ 0% |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 800 | 1.6K | 1.59K | 1.6K | 1.6K | 1.6K | 1.6K | 2K | 2K | 2K |
| Effective Tax Rate % | -0.75% | -0.24% | -0.06% | -0.03% | -0.02% | -0.01% | -0.01% | -0.01% | -0.01% | -0.01% |
| Net Income | -106.56K▲ 0% | -659.25K▼ 518.7% | -2.54M▼ 285.2% | -5.32M▼ 109.5% | -7.38M▼ 38.7% | -18.63M▼ 152.5% | -13.88M▲ 25.5% | -17.47M▼ 25.9% | -18.82M▼ 7.8% | -26.78M▲ 0% |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -242.81% | -518.67% | -285.21% | -109.52% | -38.66% | -152.55% | 25.51% | -25.87% | -7.75% | -47.32% |
| Net Income (Continuing) | -29.26K | -659.25K | -2.54M | -5.32M | -7.38M | -18.63M | -13.88M | -17.47M | -18.82M | -26.78M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.74▲ 0% | -4.50▼ 64.3% | -13.80▼ 206.7% | -26.70▼ 93.5% | -35.70▼ 33.7% | -82.20▼ 130.3% | -38.40▲ 53.3% | -23.40▲ 39.1% | -15.30▲ 34.6% | -12.19▲ 0% |
| EPS Growth % | -22.39% | -64.29% | -206.67% | -93.48% | -33.71% | -130.25% | 53.28% | 39.06% | 34.62% | 7.55% |
| EPS (Basic) | -2.74 | -4.50 | -13.80 | -26.70 | -35.70 | -82.20 | -38.40 | -23.40 | -15.30 | - |
| Diluted Shares Outstanding | 38.89K | 148.18K | 184.33K | 198.5K | 207.05K | 226.92K | 362.68K | 745.9K | 1.23M | 2.2M |
| Basic Shares Outstanding | 38.89K | 148.18K | 184.33K | 198.5K | 207.05K | 226.92K | 362.68K | 745.9K | 1.23M | 2.2M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
MODD Balance Sheet
Modular Medical, Inc. (MODD) balance sheet — assets, liabilities & shareholders' equity
| Line item | Jun'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 1.37M | 4.31M | 6.57M | 3.19M | 1.65M | 9.39M | 4.05M | 9.7M | 13.52M | 3.47M |
| Cash & Short-Term Investments | 1.37M | 4.3M | 6.55M | 3.12M | 1.47M | 9.08M | 3.8M | 9.23M | 13.1M | 2.94M |
| Cash Only | 1.37M | 4.3M | 6.55M | 3.12M | 1.47M | 9.08M | 3.8M | 9.23M | 13.1M | 2.94M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 5K | 147K | 70K | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 95K | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | 97.55 | - | - | - |
| Other Current Assets | 0 | 16.8K | 0 | 306 | 2.47K | 0 | 0 | 0 | 0 | 529K |
| Total Non-Current Assets | 0 | 20.97K | 83.63K | 672.26K | 599.08K | 456.65K | 3.2M | 4.11M | 5.22M | 6.79M |
| Property, Plant & Equipment | 0 | 13.26K | 75.95K | 572.26K | 499.08K | 356.65K | 3.2M | 4.11M | 5.22M | 6.79M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | 0.00x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 213 | 180 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 7.5K | 7.5K | 100K | 100K | 100K | 0 | 0 | 0 | 0 |
| Total Assets | 1.37M▲ 0% | 4.33M▲ 215.8% | 6.65M▲ 53.5% | 3.86M▼ 42.0% | 2.25M▼ 41.7% | 9.85M▲ 338.0% | 7.25M▼ 26.4% | 13.81M▲ 90.6% | 18.73M▲ 35.7% | 10.26M▲ 0% |
| Asset Turnover | - | - | - | - | - | - | - | - | - | 0.00x |
| Asset Growth % | - | 215.83% | 53.49% | -42% | -41.74% | 337.98% | -26.42% | 90.57% | 35.69% | 108.75% |
| Total Current Liabilities | 74.42K | 15.47K | 178.93K | 661.39K | 3.3M | 969.7K | 979K | 1.46M | 1.26M | 2.18M |
| Accounts Payable | 0 | 0 | 138.31K | 367.02K | 169.28K | 299.95K | 285K | 802K | 338K | 1.01M |
| Days Payables Outstanding | - | - | 3.49K | 3.78K | 339.8 | 555.97 | 292.66 | 381.16 | 86.09 | 310.14 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 2.5M | 0 | 0 | 0 | 0 | 464K |
| Deferred Revenue (Current) | 0 | -516 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 516 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 707K |
| Current Ratio | 18.44x | 278.81x | 36.71x | 4.82x | 0.50x | 9.68x | 4.13x | 6.66x | 10.69x | 10.69x |
| Quick Ratio | 18.44x | 278.81x | 36.71x | 4.82x | 0.50x | 9.68x | 4.04x | 6.66x | 10.69x | 10.69x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 318.74K | 226.35K | 39.96K | 1.19M | 817K | 393K | 2.2M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40K |
| Capital Lease Obligations | 0 | 0 | 0 | 178.74K | 184.35K | 39.96K | 1.19M | 817K | 393K | 671K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 140K | 42K | 0 | -33 | 0 | 0 | 2.16M |
| Total Liabilities | 74.42K | 15.47K | 178.93K | 980.13K | 3.52M | 1.01M | 2.17M | 2.27M | 1.66M | 4.38M |
| Total Debt | 21.26K | 516 | 0 | 270.95K | 2.81M | 184.81K | 1.55M | 1.19M | 816K | 504K |
| Net Debt | -1.35M | -4.3M | -6.55M | -2.85M | 1.34M | -8.89M | -2.25M | -8.04M | -12.28M | -2.43M |
| Debt / Equity | 0.02x | 0.00x | - | 0.09x | - | 0.02x | 0.30x | 0.10x | 0.05x | 0.05x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.02x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | 0.10x |
| Interest Coverage | -1.90x | - | - | - | -184.38x | -5.77x | - | - | - | - |
| Total Equity | 1.3M▲ 0% | 4.32M▲ 232.7% | 6.47M▲ 49.9% | 2.88M▼ 55.5% | -1.28M▼ 144.3% | 8.84M▲ 793.0% | 5.08M▼ 42.6% | 11.54M▲ 127.2% | 17.08M▲ 48.0% | 5.88M▲ 0% |
| Equity Growth % | 769.88% | 232.75% | 49.9% | -55.54% | -144.3% | 793% | -42.56% | 127.25% | 48.05% | 79.89% |
| Book Value per Share | 33.38 | 29.15 | 35.12 | 14.50 | -6.16 | 38.94 | 14.00 | 15.46 | 13.84 | 2.68 |
| Total Shareholders' Equity | 1.3M | 4.32M | 6.47M | 2.88M | -1.28M | 8.84M | 5.08M | 11.54M | 17.08M | 5.88M |
| Common Stock | 3.5K | 15.98K | 17.84K | 17.87K | 6.3K | 10.46K | 10.95K | 32K | 54K | 84K |
| Retained Earnings | -384.4K | -708.66K | -3.25M | -8.57M | -15.95M | -34.58M | -48.46M | -65.93M | -84.75M | -106.61M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 19.8K | 923.99K | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MODD Cash Flow Statement
Modular Medical, Inc. (MODD) cash flow — operating, investing & free cash flow history
| Line item | Jun'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -94.81K | -791.13K | -1.81M | -4.09M | -5.91M | -10.26M | -11.01M | -13.95M | -15.72M | -15.72M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -789.15% | -734.44% | -128.53% | -126.49% | -44.3% | -73.64% | -7.33% | -26.7% | -12.67% | -192.81% |
| Net Income | -106.56K | -659.25K | -2.54M | -5.32M | -7.38M | -18.63M | -13.88M | -17.47M | -18.82M | -26.78M |
| Depreciation & Amortization | 0 | 1.86K | 14.47K | 35.43K | 181.84K | 117.49K | 152.4K | 768K | 1.06M | 1.56M |
| Stock-Based Compensation | 0 | 0 | 532.11K | 801.24K | 1.23M | 4.03M | 2.72M | 2.7M | 2.38M | 2.44M |
| Deferred Taxes | 0 | 0 | 0 | -341.86K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -3 | 3.72K | 19.8K | 341.86K | 121.04K | 3.85M | 202.67K | 143K | 52K | 140K |
| Working Capital Changes | 11.75K | -133.75K | 165.19K | 389.36K | -61.15K | 374.99K | -211.82K | -94K | -392K | 389K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | -109.75K | 0 | 530.25K | 0 | 0 | -200.76K | 458K | 0 | 593K |
| Cash from Investing | 0 | -15.33K | -77.12K | -260.79K | -109.67K | -54.76K | -1.64M | -1.7M | -2.49M | -3.88M |
| Capital Expenditures | 0 | -15.33K | -77.12K | -260.79K | -109.67K | -54.76K | -1.64M | -1.7M | -2.49M | -3.88M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -213 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 1.47M | 4.71M | 4.14M | 923.99K | 4.36M | 17.92M | 7.37M | 21.09M | 22.08M | 22.07M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 2.58M | 4.14M | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | -14.1K | 4.73M | 4.14M | 923.99K | 1.79M | 13.79M | 7.37M | 20.34M | 20.82M | 22.07M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -14.1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 1.48M | -20.74K | -516 | 0 | 0 | 0 | -347 | 742K | 1.25M | 5K |
| Net Change in Cash | 1.37M▲ 0% | 3.9M▲ 184.5% | 2.26M▼ 42.2% | -3.43M▼ 252.0% | -1.65M▲ 51.8% | 7.61M▲ 560.1% | -5.28M▼ 169.4% | 5.43M▲ 203.0% | 3.86M▼ 28.9% | -4.05M▲ 0% |
| Free Cash Flow | -94.81K▲ 0% | -806.46K▼ 750.6% | -1.89M▼ 133.7% | -4.36M▼ 131.1% | -6.02M▼ 38.2% | -10.31M▼ 71.4% | -12.65M▼ 22.6% | -15.65M▼ 23.7% | -18.21M▼ 16.4% | -26.12M▲ 0% |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -789.15% | -750.61% | -133.74% | -131.06% | -38.17% | -71.38% | -22.64% | -23.74% | -16.36% | -54.2% |
| FCF per Share | -2.44 | -5.44 | -10.23 | -21.94 | -29.07 | -45.45 | -34.88 | -20.98 | -14.76 | -14.76 |
| FCF Conversion (FCF/Net Income) | 0.89x | 1.20x | 0.71x | 0.77x | 0.80x | 0.55x | 0.79x | 0.80x | 0.84x | 0.98x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 262K | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 1.6K | 1.59K | 1.6K | 1.6K | 1.6K | 2K | 2K | 2K | 0 |
MODD Key Ratios
Modular Medical, Inc. (MODD) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -19.3% | -23.47% | -47.06% | -113.79% | -920.36% | -492.82% | -199.51% | -210.34% | -131.58% | -245.85% |
| Return on Invested Capital (ROIC) | - | -2189.31% | - | -14725.81% | -11498.11% | -163356.22% | -752.33% | -416.38% | -344.61% | -344.61% |
| Debt / Equity | 0.02x | 0.00x | - | 0.09x | - | 0.02x | 0.30x | 0.10x | 0.05x | 0.05x |
| Interest Coverage | -1.90x | - | - | - | -184.38x | -5.77x | - | - | - | - |
| FCF Conversion | 0.89x | 1.20x | 0.71x | 0.77x | 0.80x | 0.55x | 0.79x | 0.80x | 0.84x | 0.98x |
MODD SEC Filings & Documents
Modular Medical, Inc. (MODD) SEC filings — annual & quarterly reports (10-K, 10-Q)
MODD Frequently Asked Questions
Modular Medical, Inc. (MODD) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Modular Medical, Inc. (MODD) grew revenue by 0.0% over the past year. Growth has been modest.
Modular Medical, Inc. (MODD) reported a net loss of $26.8M for fiscal year 2025.
Dividend & Returns
Modular Medical, Inc. (MODD) has a return on equity (ROE) of -131.6%. Negative ROE indicates the company is unprofitable.
Modular Medical, Inc. (MODD) had negative free cash flow of $26.1M in fiscal year 2025, likely due to heavy capital investments.
Explore More MODD
Modular Medical, Inc. (MODD) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates